Literature DB >> 6575211

Primary harderian gland neoplasms in mice.

W G Sheldon, M Curtis, R L Kodell, L Weed.   

Abstract

Five hundred and seventy-four spontaneous harderian gland neoplasms were observed in 3,123 male and 9,024 female untreated experimental mice of various ages and of 6 inbred strains and substrains and 3 hybrid stocks. Adenomas occurred in 86 males and 458 females, and adenocarcinomas were present in 3 males and 27 females. The highest tumor incidence occurred in mice after 24 months of age; no tumors were observed in any mice prior to 6 months of age. With the exception of 1 age group, both sexes of the BALB/c mice had the highest incidence, and also this strain accounted for 463 of the neoplasms. The adenomas were classified into one of four different histologic types: papillary, cystic papillary, acinar, and cystic. The papillary type was the most frequently observed in both sexes. The cystic papillary type was the second most frequently observed and was the type most frequently associated with gross lesions. This type may represent a developmental variant of the papillary type. The incidence of the acinar type was similar in both sexes. The cystic type had the lowest incidence. All except 3 adenocarcinomas appeared to evolve from adenomas, with evolvement occurring primarily in the acinar type. Five of the adenocarcinomas either metastasized to the lung or invaded periorbital tissues. The remaining 25 were confined to the harderian gland.

Entities:  

Mesh:

Year:  1983        PMID: 6575211

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  2 in total

Review 1.  The harderian gland: its tumors and its relevance to humans.

Authors:  D M Albert; W C Frayer; H E Black; S J Massicotte; D N Sang; J Soque
Journal:  Trans Am Ophthalmol Soc       Date:  1986

2.  Spontaneous harderian gland adenocarcinoma in a female f344 rat: a case report.

Authors:  Hideki Senoh; Taku Katagiri; Kenji Takanobu; Yumi Umeda; Shigetoshi Aiso; Shoji Fukushima
Journal:  J Toxicol Pathol       Date:  2014-01-31       Impact factor: 1.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.